# Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke

> **NCT01428310** · PHASE1 · COMPLETED · sponsor: **Rock Creek Pharmaceuticals, Inc.** · enrollment: 109 (actual)

## Conditions studied

- Tobacco Use Disorder
- Tobacco Dependence
- Smoking

## Interventions

- **DIETARY_SUPPLEMENT:** Anatabloc(TM)
- **DIETARY_SUPPLEMENT:** CigRx(R)

## Key facts

- **NCT ID:** NCT01428310
- **Lead sponsor:** Rock Creek Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-10
- **Final completion:** 2011-12
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01428310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01428310, "Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01428310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*